DLL1 Gene

📖 Wiki Page

gene1700 wordssynced 2026-04-02

DLL1 Gene

...

DLL1 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">DLL1 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>DLL1</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Delta-Like 1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>6q27</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>28514</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>604552</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000198719</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>O00548</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>723 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~82 kDa</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Brain (hippocampus, cortex, SVZ), neural stem cells, neurons, astrocytes</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>AD, PD, neurodevelopmental disorders, cancer</td>
</tr>
<tr>
<td class="label">AD Feature</td>
<td>DLL1-Notch Role</td>
</tr>
<tr>
<td class="label">Amyloid pathology</td>
<td>Aβ inhibits DLL1</td>
</tr>
<tr>
<td class="label">Neurogenesis decline</td>
<td>DLL1-Notch required</td>
</tr>
<tr>
<td class="label">Synapse loss</td>
<td>Regulates synaptic proteins</td>
</tr>
<tr>
<td class="label">Cognitive decline</td>
<td>Required for memory</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">DLL1 agonists</td>
<td>Soluble DLL1-Fc fusion proteins</td>
</tr>
<tr>
<td class="label">Notch agonists</td>
<td>Small molecule Notch activators</td>
</tr>
<tr>
<td class="label">ADAM10 inhibitors</td>
<td>Increase DLL1-Notch by reducing receptor cleavage</td>
</tr>
<tr>
<td class="label">Gamma-secretase inhibitors</td>
<td>Complex (ICV delivery, risk of side effects)</td>
</tr>
<tr>
<td class="label">Stem cell therapy</td>
<td>DLL1-expressing neural stem cells</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-DLL1 delivery to hippocampus</td>
</tr>
</table>

DLL1 (Delta-Like 1) encodes a transmembrane ligand of the Delta/Serrate/Lag-2 (DSL) family that activates Notch receptors through cell-cell contact. DLL1 is the principal Notch ligand in the adult brain, where it critically regulates [neural stem cell](/mechanisms/neural-stem-cells) maintenance, adult [neurogenesis](/mechanisms/neurogenesis), synaptic plasticity, and neuronal survival. Dysregulation of DLL1-Notch signaling has been strongly implicated in [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis, where [amyloid-beta](/proteins/amyloid-beta) disrupts Notch-dependent processes, and in [Parkinson's disease](/diseases/parkinsons-disease), where impaired Notch signaling contributes to [dopaminergic neuron](/cell-types/dopaminergic-neurons) vulnerability[@lathia2007][@conti2019].

Overview

Gene Structure and Expression

Genomic Organization

The DLL1 gene spans approximately 20 kb on chromosome 6q27 and contains 24 exons. The gene is regulated by multiple promoters and enhancers that control its spatial and temporal expression pattern[@artavanistsakonas2000].

Expression Pattern

DLL1 is expressed in a dynamic pattern during development and in the adult brain[@litwack2004][@castillo2016]:

Neural stem cells: High expression in the [subventricular zone](/brain-regions/ventricular-system) (SVZ) and [hippocampal subgranular zone](/brain-regions/hippocampus) (SGZ), where it maintains stem cell identity through lateral inhibition
Postmitotic neurons: Expressed in hippocampal and cortical neurons, where it modulates synaptic function
Astrocytes: Lower expression in astrocytes, suggesting potential paracrine Notch ligand activity
Oligodendrocyte precursors: Expression during differentiation suggests a role in myelination

Expression is activity-dependent: synaptic activity upregulates DLL1 in excitatory neurons, providing a feedback mechanism linking circuit activity to Notch-mediated gene expression[@wang2009].

Protein Structure

Domain Architecture

The DLL1 protein contains several critical structural elements[@artavanistsakonas2000]:

N-terminal DSL domain: Conserved region essential for binding to Notch receptors

EGF-like repeats: Eight EGF-like repeats mediating receptor-ligand interaction

MNNL domain: Module at the N-terminus involved in protein interactions

Transmembrane helix: Single pass transmembrane domain anchoring DLL1 to the plasma membrane

C-terminal intracellular domain: Short cytoplasmic tail involved in signal transduction

Post-Translational Modifications

DLL1 undergoes several modifications that regulate its function:

O-fucosylation: Glycosylation by POFUT1 is required for proper Notch binding
N-glycosylation: Multiple N-linked glycosylation sites modulate protein stability
Proteolytic cleavage: Shedding by ADAM proteases generates soluble DLL1 fragments with signaling activity
Palmitoylation: Lipid modification facilitates membrane organization and signaling

Normal Physiological Function

Notch Signaling Pathway

The DLL1-Notch pathway is a fundamental mechanism for cell-cell communication in the nervous system[@artavanistsakonas2000][@lathia2007]:

Mermaid diagram (expand to render)

Neural Stem Cell Maintenance

In the adult brain, DLL1-Notch signaling is the primary mechanism maintaining neural stem cell identity[@litwack2004]:

Lateral inhibition: DLL1-expressing neural progenitors activate Notch in neighboring cells, preventing their differentiation and maintaining the stem cell pool
Self-renewal signaling: Constitutive Notch activation promotes proliferation of stem cells without premature differentiation
Niche maintenance: DLL1 from niche cells (ependymal cells, astrocytes) provides essential Notch activation to stem cells

Neurogenesis Regulation

Adult neurogenesis in the [hippocampus](/brain-regions/hippocampus) and [SVZ](/brain-regions/ventricular-system) is regulated by DLL1-Notch signaling[@castillo2016]:

Type 1 → Type 2 transition: DLL1-Notch signaling inhibits the transition from active stem cells to transit-amplifying cells
Dendrite development: Notch activation regulates dendritic morphology of newborn neurons
Synapse formation: DLL1 at presynaptic terminals modulates postsynaptic Notch receptors during synapse formation
Integration: Proper Notch signaling is required for the functional integration of new neurons into hippocampal circuits

Synaptic Plasticity

DLL1 at synapses regulates activity-dependent synaptic modification[@wang2009][@ables2010]:

Hippocampal LTP: DLL1-Notch signaling is required for long-term potentiation in CA1 neurons
Dendritic spine morphology: DLL1 modulates spine density and shape through Notch-dependent gene expression
Learning and memory: Impaired Notch signaling disrupts hippocampus-dependent spatial memory
Molecular pathways: DLL1-Notch activates CREB and regulates PSD-95, Synapsin, and NMDA receptor subunit expression

Disease Associations

Alzheimer's Disease

DLL1-Notch signaling is profoundly dysregulated in AD through multiple mechanisms[@lathia2007][@brai2012][@song2014]:

Amyloid-beta inhibition: Aβ directly downregulates DLL1 expression in neural stem cells and neurons, impairing Notch signaling
Neurogenesis impairment: Aβ-mediated DLL1-Notch disruption reduces hippocampal neurogenesis, which is critical for memory formation
Synaptic dysfunction: DLL1-Notch signaling regulates synaptic proteins; disruption contributes to synapse loss in AD
Microglial modulation: Notch signaling in microglia promotes inflammatory states; DLL1 from neurons may modulate microglial activation
APP processing crosstalk: Notch and APP share processing enzymes (ADAM10, gamma-secretase), creating bidirectional regulation

Parkinson's Disease

DLL1 contributes to PD pathophysiology through several pathways[@conti2019]:

Dopaminergic neuron survival: Notch signaling provides trophic support to [substantia nigra](/brain-regions/substantia-nigra) dopaminergic neurons
Neuroinflammation: DLL1-Notch in microglia and astrocytes modulates inflammatory responses that drive PD progression
Protein aggregation crosstalk: Alpha-synuclein and Notch pathway interactions have been identified in PD models
Mitochondrial dysfunction: Notch signaling influences mitochondrial quality control pathways relevant to PD
Neurorestoration potential: Enhancing DLL1-Notch signaling may promote compensatory neurogenesis in PD

Neurodevelopmental Disorders

DLL1 mutations and dysregulation contribute to developmental brain disorders:

Neurodevelopmental disorders: Altered Notch signaling contributes to autism spectrum disorders, intellectual disability, and schizophrenia
Brain malformation: DLL1 mutations can cause cortical patterning defects
Synaptic development: DLL1-Notch at the synapse regulates excitatory/inhibitory balance

Cancer

Like many growth/survival pathways, DLL1-Notch has context-dependent roles in cancer:

Tumor suppressor in some tissues: DLL1 is frequently silenced in breast, lung, and colorectal cancers
Oncogenic in others: In certain contexts, DLL1-Notch promotes cancer stem cell maintenance
Therapeutic targeting: DLL1-Notch pathway modulators are in cancer clinical trials

Therapeutic Implications

DLL1-Notch Modulation Strategies

Approaches to therapeutically modulate DLL1-Notch signaling in neurodegeneration[@lathia2007][@conti2019]:

Clinical Considerations

Complexity of Notch signaling: Notch has context-dependent pro-survival and pro-differentiation effects, requiring careful targeting
Blood-brain barrier: DLL1-Fc fusion proteins may require intrathecal or intraventricular delivery
Developmental toxicity: Notch modulators risk affecting normal brain development
Combination approaches: DLL1-Notch enhancement may synergize with anti-amyloid therapies

Biomarker Potential

DLL1 expression and Notch pathway activity may serve as:

Neurogenesis marker: DLL1 levels in CSF or blood may reflect hippocampal neurogenesis rate
AD progression marker: DLL1 expression inversely correlates with amyloid burden and cognitive decline
Treatment response indicator: DLL1-Notch activity may predict response to neurogenesis-enhancing therapies

Animal Models

Dll1 Knockout Mice

Embryonic lethality: Dll1 null mice die around E13.5 with severe neural tube defects
Conditional knockouts: Neuron-specific Dll1 deletion reveals role in synaptic plasticity
Conditional knockout phenotypes: Impaired LTP, reduced dendritic spines, spatial memory deficits

Dll1 haploinsufficiency

Viable: Dll1+/- mice survive with subtle phenotypes
Increased neurogenesis: Paradoxically, reduced Notch signaling can release stem cells to differentiate
Behavioral deficits: Learning and memory impairments

Transgenic overexpression

Neuronal DLL1 OE: Enhanced neurogenesis and improved spatial memory
Overexpression in AD models: Partial rescue of Aβ-induced neurogenesis deficits

Signaling Pathways and Interactions

Molecular Interactions

Key DLL1-Notch pathway interactions[@artavanistsakonas2000]:

Notch receptors: NOTCH1 (primary), NOTCH2, NOTCH3 (redundant roles in neural cells)
RBPJkappa (CBF1): Transcription factor recruited by NICD to Notch target gene promoters
Mastermind-like (MAML): Co-activator recruited with RBPJkappa
HDAC complexes: Repressed by Notch signaling (negative regulation)
NUMB: Endocytic adaptor that degrades Notch, creating asymmetry in divisions

Downstream Targets

Notch activation by DLL1 regulates expression of[@ables2010][@castillo2016]:

Transcription factors: Hes1, Hes5, Hey1 (repressors of differentiation genes)
Cell cycle regulators: Myc, CyclinD1 (promote stem cell proliferation)
Synaptic proteins: PSD-95, Synapsin, NR2A, NR2B subunits
Anti-apoptotic proteins: Bcl-2, Bcl-xL
extracellular matrix: Reelin, which modulates synaptic function

Research Directions

Current Priorities

Key research areas for DLL1 include[@conti2019][@brai2012]:

Mechanism of Aβ inhibition: How does Aβ downregulate DLL1 and Notch signaling?

Therapeutic delivery: Developing DLL1 agonists that cross the blood-brain barrier

Cell-specific targeting: Identifying neurons vs. stem cells where DLL1 modulation would be most beneficial

Combination therapies: DLL1-Notch enhancement with anti-amyloid or anti-tau approaches

Neurogenesis enhancement: Using DLL1 modulation to boost hippocampal neurogenesis in AD

Biomarker development: DLL1 as a marker of neurogenic capacity in AD patients

Emerging Questions

Does DLL1 expression predict response to anti-amyloid immunotherapies?
Can DLL1-Notch modulation protect against tau pathology as well as amyloid?
What is the role of astrocyte-derived DLL1 vs. neuron-derived DLL1 in disease?
Are DLL1-Notch effects on neuroinflammation disease-stage dependent?

Summary

DLL1 encodes the principal Notch ligand in the adult brain, critical for neural stem cell maintenance, adult neurogenesis, and synaptic plasticity. In Alzheimer's disease, amyloid-beta disrupts DLL1-Notch signaling, contributing to impaired neurogenesis and synaptic dysfunction. In Parkinson's disease, DLL1-Notch supports dopaminergic neuron survival and modulates neuroinflammation. Therapeutic targeting of DLL1-Notch signaling represents a regenerative approach to neurodegenerative disease, though careful consideration of pathway complexity and delivery challenges is needed.

External Links

[DLL1 - NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/28514)
[DLL1 Protein - UniProt](https://www.uniprot.org/uniprot/O00548)
[DLL1 - GeneCards](https://www.genecards.org/cgi-bin/carddisp.pl?gene=DLL1)
[OMIM: 604552](https://www.omim.org/entry/604552)
[Ensembl: ENSG00000198719](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000198719)

Pathway Diagram

The following diagram shows the key molecular relationships involving DLL1 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

DLL1 Gene

DLL1 Gene

DLL1 Gene

Overview

Gene Structure and Expression

Genomic Organization

Expression Pattern

Protein Structure

Domain Architecture

Post-Translational Modifications

Normal Physiological Function

Notch Signaling Pathway

Neural Stem Cell Maintenance

Neurogenesis Regulation

Synaptic Plasticity

Disease Associations

Alzheimer's Disease

Parkinson's Disease

Neurodevelopmental Disorders

Cancer

Therapeutic Implications

DLL1-Notch Modulation Strategies

Clinical Considerations

Biomarker Potential

Animal Models

Dll1 Knockout Mice

Dll1 haploinsufficiency

Transgenic overexpression

Signaling Pathways and Interactions

Molecular Interactions

Downstream Targets

Research Directions

Current Priorities

Emerging Questions

Summary

See Also

External Links

Pathway Diagram